Suppression of thyrotropin (h-TSH) in serums of patients with myxedema of varying etiology treated with thyroid hormones.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy; D007456:Iodine Isotopes / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D011863:Radioimmunoassay; D013965:Thyroidectomy; D013967:Thyroiditis, Autoimmune / Q000150:complications; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000008:administration & dosage* / Q000097:blood; D014284:Triiodothyronine / Q000008:administration & dosage*
D007456:Iodine Isotopes; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine